Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Skin and Connective Tissue Diseases | 0.900 | 1.000 | 15 | 2006 | 2019 | |||||||
|
0.851 | 0.280 | 1 | 152328341 | intron variant | G/A | snv | 0.29 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.810 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 16 | 2006 | 2018 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.780 | 1.000 | 12 | 2007 | 2019 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.740 | 1.000 | 13 | 2006 | 2013 | |||||||
|
0.925 | 0.120 | 1 | 152286602 | intron variant | A/G | snv | 0.15 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.710 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.710 | 1.000 | 2 | 2007 | 2019 | |||||||
|
0.851 | 0.160 | 1 | 152312601 | frameshift variant | ACTG/- | delins | 1.3E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 7 | 2006 | 2016 | |||||||
|
1.000 | 1 | 152307855 | stop gained | G/C | snv | 4.7E-04 | 9.8E-05 |
|
0.700 | 1.000 | 6 | 1966 | 2013 | ||||||||
|
1.000 | 1 | 152307855 | stop gained | G/C | snv | 4.7E-04 | 9.8E-05 |
|
Nervous System Diseases | 0.700 | 1.000 | 6 | 1966 | 2013 | |||||||
|
1.000 | 1 | 152307855 | stop gained | G/C | snv | 4.7E-04 | 9.8E-05 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 6 | 1966 | 2013 | |||||||
|
1.000 | 0.080 | 1 | 152312743 | stop gained | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 5 | 2006 | 2012 | ||||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2006 | 2006 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2006 | 2006 | |||||||
|
0.658 | 0.640 | 1 | 152313385 | stop gained | G/A;T | snv | 9.4E-03; 8.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases | 0.700 | 1.000 | 4 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 1 | 152206676 | intron variant | C/T | snv | 2.9E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 1 | 152309169 | stop gained | G/A;T | snv | 8.0E-06; 1.6E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2006 | 2006 | |||||||
|
1.000 | 0.080 | 1 | 152307697 | stop gained | G/A;C | snv | 1.6E-05; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2011 | 2013 | |||||||
|
1.000 | 0.040 | 1 | 152325736 | intron variant | G/A | snv | 0.19 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 1 | 152206676 | intron variant | C/T | snv | 2.9E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 1 | 152206676 | intron variant | C/T | snv | 2.9E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 1 | 152206676 | intron variant | C/T | snv | 2.9E-02 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 1 | 152189630 | non coding transcript exon variant | A/G | snv | 0.23 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 1 | 152189630 | non coding transcript exon variant | A/G | snv | 0.23 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 1 | 152329259 | intron variant | A/G | snv | 0.31 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 |